Our finding that MP preferentially inhibits JAK/STAT signaling in T cells but not in myeloid cells after surgery raises the possibility that the perioperative use of GCs may negatively affect the balance between immune mechanisms required for wound repair and tumor surveillance, including tumor-specific T-cells. This evidence concerns the gene SOAT1 and neoplasm.